This volume in the Handbook of Clinical Neurology (Series Editors:: Michael J. Aminoff, Department of Neurology, University of California, San Francisco, USA; François Boller, Bethesda, USA; Dick F. Swaab, Netherlands Institute for Neuroscience, Amsterdam, the Netherlands) is the first major account of the human hypothalamus. The human hypothalamus is an extremely complex structure and consists of a large number of very different functional units (nuclei) that are not included in the standard neuropathological investigation of the human brain. In fact, on the basis of their chemical nature, many of these functional systems have only recently been distinguished through modern neurobiological techniques. Since the finding that the hypothalamus contributes to memory and attention deficits in the dementias, that a disorder of the orexin/hypocretin system is the cause of narcolepsy, that hypothalamic hamartomas are responsible for gelastic epilepsy, that the subthalamic structure where depth electrodes are placed in parkinsonian patients is a hypothalamic structure, and that the source of cluster headache is situated in the hypothalamus, this perception of the hypothalamus as a neuroendocrine structure, of limited interest to neurologists and psychiatrists, is rapidly changing. Moreover, the hypothalamus now appears to be the basis of many signs and symptoms of disorders situated on the border between neurology and psychiatry, such as depression, eating disorders, aggression, and mental retardation. As a consequence, the hypothalamus has become a meeting point for neuroscientists, neurologists and psychiatrists, endocrinologists, and pediatricians, and as such is an important starting point for the new (third) series of the Handbook of Clinical Neurology.
Part I. Nuclei of the human hypothalamus: cytoarchitecture, chemoarchitecture, functional neuroanatomy, topographic neuropathology.
1. Introduction. 1.1 Anatomical borders of the hypothalamus. 1.2 Strategic research and structure-function relationships. 1.3 The autopsy and brain banking. 1.4 Confounding factors. 1.5 Parameters of neuronal metabolic activity in postmortem tissue. 1.6 Fetal hypothalamic development and adult markers of the human hypothalamic nuclei. 2. Nucleus basalis of Meynert (NBM) and diagonal band of Broca (DBB). 2.1 Anatomy. 2.2 Chemoarchitecture. 2.3 Alzheimers disease. 2.4 Neuronal loss vs. atrophy. 2.5 Neurotrophin receptors in the NBM. 2.6 Other disorders affecting the NBM and DBB. 3. Islands of Calleja, insulae terminalis. 4. Suprachiasmatic nucleus (SCN) and pineal gland. 4.1 Circadian, seasonal, monthly and circaseptan rhythms in the SCN. 4.2 SCN development, birth and circadian rhythms. 4.3 Circadian and circannual rhythms in aging and Alzheimers disease. 4.4 The SCN in relation to sex, reproduction and sexual orientation. 4.5 Melatonin and its receptors. 5. Sexually dimorphic nucleus of the preoptic area (SDN-POA) = intermediate nucleus = interstitial nucleus of the anterior hypothalamus (INAH-1) = preoptic nucleus. 5.1 Nomenclature and homology to the rat SDN-POA. 5.2 Development, sexual differentiation, aging and Alzheimers disease. 6. Other sexual dimorphisms. 6.1. Interstitial nucleus of the anterior hypothalamus (INAH)-2 and -3. 6.2 Anterior commissure, the interthalamic adhesion, corpora mamillaria and the third ventricle. 6.3 Sex hormone receptor distribution. 7. Bed nucleus of the stria terminalis (BST) and the septum. 7.1 The BST. 7.2 Reversed sex differences in the BST in transsexuals. 7.3 The septum verum. 8. Supraoptic and paraventricular nucleus (SON, PVN). 8.1 The fetal SON, PVN in birth and development. 8.2 Colocalization of tyrosine-hydroxylase (TH) with oxytocin and vasopressin. 8.3 The SON and PVN in aging and Alzheimers disease. 8.4 (a) Vasopressin secretion in various disorders: (b) Vasopressin administration in various disorders. 8.5 Corticotropin-releasing hormone (CRH) neurons in the PVN. 8.6 Thyrotropin-releasing hormone (TRH) neurons in the PVN. 8.7 Other neuroactive compounds in the SON, PVN and periventricular nucleus. 9. Ventromedial nucleus (VMN; nucleus of Cajal). 10. Dorsomedial nucleus (DMN). 11. Infundibular nucleus (arcuate nucleus), subventricular nucleus and median eminence. 12. Lateral tuberal nucleus (NTL). 12.1 Chemoarchitecture and function. 12.2 The NTL in neurodegenerative diseases. 13. Tuberomamillary complex. 13.1 Anatomy. 13.2 Neurodegenerative diseases and schizophrenia. 13.3 Posterior hypothalamic area. 14. Lateral hypothalamic area (LHA) and intermediate hypothalamic area (IHA). 15. Subthalamic nucleus and zona incerta. 15.1 Subthalamic nucleus. 15.2 Zona incerta. 16. Corpora mamillaria. References.
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.